Get the Stockscreener App
0.32
6.63%
0.0199
Petros Pharmaceuticals Inc stock is traded at $0.32, with a volume of 210.98K.
It is up +6.63% in the last 24 hours and up +8.70% over the past month.
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.
See More
Previous Close:
$0.3001
Open:
$0.33
24h Volume:
210.98K
Relative Volume:
0.11
Market Cap:
$3.20M
Revenue:
$4.02M
Net Income/Loss:
$-4.73M
P/E Ratio:
-0.076
EPS:
-4.21
Net Cash Flow:
$-5.85M
1W Performance:
+3.06%
1M Performance:
+8.70%
6M Performance:
-25.58%
1Y Performance:
-73.55%
1-Day Range:
$0.3004
$0.33
1-Week Range:
$0.288
$0.33
52-Week Range:
$0.2208
$2.27
Petros Pharmaceuticals Inc Stock (PTPI) Company Profile
Name
Petros Pharmaceuticals Inc
Sector
Phone
973-242-0005
Address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK
Compare PTPI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PTPI
Petros Pharmaceuticals Inc
|
0.32 | 3.20M | 4.02M | -4.73M | -5.85M | -4.21 |
|
ZTS
Zoetis Inc
|
167.53 | 75.58B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.82 | 24.72B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
145.88 | 14.77B | 2.24B | 385.90M | 440.10M | 3.73 |
Petros Pharmaceuticals Inc Stock (PTPI) Latest News
Comparing Petros Pharmaceuticals (NASDAQ:PTPI) & MoonLake Immunotherapeutics (NASDAQ:MLTX) - Defense World
Petronas may cut capex up to RM10b after Petro gas deal - The Malaysian Reserve
Pre-market Movers: SANA, SLDB, JSPR, DRIO... - RTTNews
AMRN Stock Rises Over 5% Amidst Lack of Institutional Ratings - GuruFocus.com
GROUPIRA Co-Founder Petros Koumantaros Appointed to Washington Saves Governing Board - Yahoo Finance
Petros Pharmaceuticals Strategically Positioned to Benefit as Technology Leader from Newly Approved FDA OTC Final Rules - AccessWire
Best Penny Stocks for Today (Charts Updated Daily) - Benzinga
Pre-market Movers: ONCO, COEP, NUVB, SPRC... - RTTNews
Siga Technologies (SIGA) Stock Surges Over 5% Amid Market Activi - GuruFocus.com
Petros Pharmaceuticals Featured in “New Era of Healthcare, AI, Data and Consumer Empowerment” - AccessWire
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Siga Technologies (SIGA) Stock Drops 5.01% Amid Market Volatilit - GuruFocus.com
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket - Benzinga
Falcon’s Beyond Global Announces Mandatory Exchange of WarrantsOn December 16, 2024, Falcon’s Beyond Global, Inc. (NASDAQ: FBYD) made a significant announcement regarding the mandatory exchange of its outstanding warrants. The company reve - Defense World
Proprietary Technology Addressing the Rx-to-OTC Switch Self-Care Market Valued at over $38 Billion annually - AccessWire
Petros Pharmaceuticals faces financial obligation acceleration - Investing.com
Petros Pharmaceuticals, Inc. Announces Proprietary Technology Addressing the Rx-To-OTC Switch Self-Care Market Valued at over $38 Billion Annual - Marketscreener.com
Tarsus Pharmaceuticals: Worthy Of A Small Bet (NASDAQ:TARS❌ Ilumine seu dia com Estrela BRT - Oficjalny Portal Gminy Brzesko
Petros Pharmaceuticals faces financial obligation acceleration By Investing.com - Investing.com UK
Why Mitek Systems Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket - Benzinga
Pre-market Movers: EWTX, TNXP, LNSR, VRDN... - RTTNews
Helios Towers (LON:HTWS) Trading 0.1% Higher – Should You Buy? - Defense World
Cleanaway Waste Management (OTCMKTS:TSPCF) Stock Price Up 2.2% – Should You Buy? - Defense World
First National of Nebraska (OTCMKTS:FINN) Trading 0.8% Higher – Should You Buy? - Defense World
Petros Pharmaceuticals (NASDAQ:PTPI) Stock Price Down 5.8% – Should You Sell? - Defense World
Kuke Music (NYSE:KUKE) Shares Down 8.3% – Time to Sell? - Defense World
Patriot One Technologies (OTCMKTS:PTOTF) Stock Price Down 2.1% – What’s Next? - Defense World
Erectile Dysfunction Drugs Market Size, Growth Outlook 2025 – 2034 - Global Market Insights
Petros Pharmaceuticals announces shareholder meeting outcomes - Investing.com
Petros Pharmaceuticals Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Petros Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Petros Pharmaceuticals stock hits 52-week low at $0.28 - Investing.com
Petros Pharmaceuticals stock hits 52-week low at $0.28 By Investing.com - Investing.com Canada
It's Probably Less Likely That Petros Pharmaceuticals, Inc.'s (NASDAQ:PTPI) CEO Will See A Huge Pay Rise This Year - Simply Wall St
Bragg Gaming Group (OTCMKTS:BRGGD) Shares Down 2.2% – What’s Next? - Defense World
Short Interest in Zions Bancorporation N.A. – 6.9 (NASDAQ:ZIONL) Increases By 170.0% - Defense World
Petros Pharmaceuticals Amends President’s Employment Terms - Yahoo Finance
Petros Pharmaceuticals adjusts executive's salary and terms - Investing.com India
Petros Pharmaceuticals adjusts executive's salary and terms By Investing.com - Investing.com South Africa
Petros Pharmaceuticals amends preferred stock terms - Investing.com India
Petros Pharmaceuticals amends preferred stock terms By Investing.com - Investing.com UK
Petros Pharmaceuticals sees two board members resign By Investing.com - Investing.com Australia
Petros Pharmaceuticals sees two board members resign - Investing.com India
Board Reshuffle at Petros Pharmaceuticals Following Resignations - TipRanks
Petros Pharmaceuticals, Inc. Announces Board Resignations - Marketscreener.com
Stock Market Trending News - StockTitan
Otsuka and Lundbeck Announce Barbara Corcoran Led Campaign to Raise Awareness of Alzheimer’s Dementia - Pharmaceutical Executive
Petros Pharmaceuticals sets date for 2024 annual meeting - Investing.com
Petros Pharmaceuticals reports high comprehension in drug app study - Investing.com
Petros Pharmaceuticals Executes Successful Initial Test for App Comprehension as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil) - AccessWire
Petros Pharmaceuticals Inc Stock (PTPI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):